glp-1 receptor agonists cardiovascular benefits in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies In patients with #obesity, incretin-based

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Varin EM, et al

Because FXR agonists are the most favorable agents, they may be fundamental drugs for combination

Conservation of Glucagon Like Peptide-1 Level With Liraglutide and Linagilptin Protects the Kidney Against Angiotensin II-Induced Tissue Fibrosis in Rats

Additionally, the psychological aspects of BEDincluding emotional regulation difficulties and the functional role of binge eatingmay not be adequately addressed by medication alone

[DOI] [PubMed] [Google Scholar] 28.Cho Y.M., Fujita Y., Kieffer T.J

The mechanisms of lysosomal degradation and autophagy are crucial to remove potentially toxic and protective fatty acids against ER stress-induced cell death [129,130,131]